Ono Pharmaceutical Co., Ltd.
4528Pharmaceuticals
¥2,224.50−9.99%As of Oct 29vs prior close
- Market cap
- $6.6B
- P/E (TTM)
- 15.2×
- P/E (FY1)
- 13.8×
- From 52W high
- −14.07%
- EPS (LTM)
- ¥161.08
- Revenue (LTM)
- ¥504.4B
- Net margin
- 15.12%
- Dividend yield
- 3.60%
Nomior Score
55
Steady ProfileTop 38% of the scored universe
Growth24
Quality56
Value57
Momentum79
Resilience53
Growth
+4.87%revenue a year over 3 fiscal years
YE23 ¥447.2BLTM ¥504.4B
Connections
Revenue to profitYE26
14% of revenue became net profit, up 3 pts on a year.